Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Missouri by County

Prostate (Late Stage^), 2016-2020

All Races (includes Hispanic), Male, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.


Other Notes


Line by Line Interpretation of the Report


Missouri6


US (SEER+NPCR)1


Scott County6


Cape Girardeau County6


Perry County6


Douglas County6


Stoddard County6


Webster County6


Pulaski County6


Gasconade County6


Wayne County6


Butler County6


St. Louis County6


Dallas County6


Newton County6


St. Louis City6


Dunklin County6


Franklin County6


Audrain County6


Barry County6


Cole County6


Marion County6


Morgan County6


Callaway County6


Phelps County6


Taney County6


Laclede County6


Greene County6


Vernon County6


Stone County6


Jasper County6


Crawford County6


Pettis County6


Clinton County6


St. Charles County6


Boone County6


Jefferson County6


Platte County6


Christian County6


Jackson County6


Buchanan County6


Polk County6


Miller County6


Warren County6


Clay County6


Benton County6


Camden County6


St. Francois County6


Lincoln County6


Cass County6


Lafayette County6


Texas County6


Johnson County6


Lawrence County6


Adair County6 Andrew County6 Atchison County6 Barton County6 Bates County6 Bollinger County6 Caldwell County6 Carroll County6 Carter County6 Cedar County6 Chariton County6 Clark County6 Cooper County6 Dade County6 Daviess County6 DeKalb County6 Dent County6 Gentry County6 Grundy County6 Harrison County6 Henry County6 Hickory County6 Holt County6 Howard County6 Howell County6 Iron County6 Knox County6 Lewis County6 Linn County6 Livingston County6 Macon County6 Madison County6 Maries County6 McDonald County6 Mercer County6 Mississippi County6 Moniteau County6 Monroe County6 Montgomery County6 New Madrid County6 Nodaway County6 Oregon County6 Osage County6 Ozark County6 Pemiscot County6 Pike County6 Putnam County6 Ralls County6 Randolph County6 Ray County6 Reynolds County6 Ripley County6 Saline County6 Schuyler County6 Scotland County6 Shannon County6 Shelby County6 St. Clair County6 Ste. Genevieve County6 Sullivan County6 Washington County6 Worth County6 Wright County6

Notes:
Created by statecancerprofiles.cancer.gov on 03/28/2024 11:27 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.